Company Email Format

Cyrano Therapeutics

Pharmaceutical Manufacturing 190 Congress Park Dr 6 employees

Employees: 6
Contacts: 4
Emails: 4
Phones: 2

cyranotherapeutics.com LinkedIn Crunchbase

Cyrano Therapeutics Overview

Headquarters: 190 Congress Park Dr
Website: cyranotherapeutics.com
Industry: Pharmaceutical Manufacturing
Employees: 6
Founded: 2014
Funding: 9.0M
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

Geneve

About Cyrano Therapeutics

Cyrano Therapeutics has developed a unique, proprietary intranasal formulation to restore function in patients with a chronic loss of taste and smell. This is a condition affecting more than 40 million people in the US and Europe and millions more across the world, having a significant impact on safety, quality of life and well-being. Currently no marketed pharmaceutical therapy exists and aside from the Cyrano product, none are in the pipeline. The Cyrano formulation (CYR-064) has been tested with success in a 92 patient pilot study and the Company is currently enrolling patients in a Phase 2 placebo-controlled double-blind randomized trial at 14 sites in the United States with data readout expected in Q1'25. Additional information can be found on our website www.cyranotherapeutics.com

Cyrano Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

Cyrano Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
John Kollins	Biopharma CEO, C-suite Executive	San Francisco, California, United States	Email Phone
Gerry Brunk	Managing Director at Lumira Ventures	Greater Boston, United States	Email
Rick Gordon	Co-founder and CEO, Tidal Cyber	Washington, District of Columbia, United States	Email
Rick Geoffrion		Jupiter, Florida, United States	Email Phone